Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 1 year ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more
Research Area(s) / Expertise:
Personal History Dr Carolyn Webb is based in London, where she works as a research fellow at the National Heart and Lung Institute. Academic History Carolyn studied physiology as an undergraduate at the University of Otago, New Zealand. Then she went on to obtain her PhD in education at Imperial College London. Career Overview Carolyn Webb is a research fellow at the… View more
Research Area(s) / Expertise: Job title: Professor and Chairman, Division of Cardiovascular Medicine
Dr. Shimokawa graduated from Kyushu University in 1979 and obtained MD and PhD degrees at the University. He studied at the Mayo Clinic in 1985-1987 and was appointed as an assistant professor at Kyushu University in 1991, and then associate professor in 1995. In 2005, he was appointed as the professor and chairman of the Department of Cardiovascular Medicine, Graduate School of Medicine, Tohoku… View more